All Articles

As Continual-G expands across the US with bold scientific claims, it highlights a growing trend and a critical question: is this the future of wellness, or just for the wealthy?

As Springboard Wine & Spirits elevates a new sales leader, a deeper look reveals a strategy where culture isn't just a buzzword—it's the core asset.

As global infrastructure crumbles, a new AI framework from South Korea uses drones and 3D models to predict failures, promising safer bridges and huge savings.

From Amazon retail to darknet intelligence, Nexera's LOI with Nebo signals a bold pivot. Can this bet on proactive data center security redefine its future?

A South Korean lab has cracked a key battery problem, promising safer, ultra-fast EV charging. But can this new anode design outpace global rivals?

Curium's landmark $8 billion acquisition of Lantheus is set to create a global powerhouse in nuclear medicine, reshaping patient care and the competitive landscape.

A new defense tech player just landed a major Air Force deal. We go beyond the headlines to reveal the financial machinery and strategic plays driving it.

Enterprise AI leader Yellow.ai is going public via a SPAC merger, aiming to deploy autonomous agents and disrupt the massive $900 billion BPO industry.

As Students 2 Science founder Dr. Paul Winslow steps back, the nonprofit signals a new growth phase by promoting a proven leader from within its own ranks.

Autolus Therapeutics reports a 100% year-over-year sales jump and a stunning gross margin reversal, securing a $250M credit facility to fund its next big move.

Biocon's Yesafili, an interchangeable biosimilar to the $5.9B eye drug Eylea, launches in the US, promising major cost savings and market disruption.

Robinson Helicopter's new 10-seat R88 debuts in Brazil, targeting a critical gap in the market. Is this the cost-effective workhorse the region needs?

ADAMA's appointment of a top M&A lawyer as General Counsel reveals a strategy focused on global growth, innovation, and navigating a complex ag-tech landscape.

With blockbuster sales for its MS drug BRIUMVI, TG Therapeutics is raising revenue targets and aggressively expanding its pipeline into new diseases.

Zac Brown Band's cruise giveaway is more than a thank you; it's a blueprint for deep brand integration and a new, high-stakes era of fan engagement.

Fresh off a $260M IPO, Seaport Therapeutics is advancing a de-risked pipeline for depression and anxiety, leveraging its novel platform to unlock new potential.

Lipocine's appointment of M&A veteran Michael Grissinger isn't just a new face on the board; it's a clear signal of a strategic pivot towards high-stakes partnerships.

The German prosthetics giant just built its first US facility from scratch. It’s more than a clinic; it's a bet on transparency, community, and the 2028 Paralympics.

Beyond its star-studded Seattle gala, the Asian Hall of Fame is pioneering a new philanthropic model focused on neurodiversity, women in tech, and legacy.

As AI models multiply, 'subscription fatigue' is overwhelming users. A new service, Ask-Chat.ai, bundles 20+ top AIs, signaling a market shift toward aggregation.